Clinical trial

Closed-Loop Impact on Chronic Kidney Disease in Type 2 Diabetes

NCT06925217

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-06-16

PhaseNA

Study timeline

Study start (actual)2025-06-16Date precision: day

Registry last updated2026-02-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesverified · MONDO: type 2 diabetes mellitus

Chronic Kidney Disease Stage 3unresolved

Interventions

CamAPS HXDEVICE

Standard insulin therapy with CGMDEVICE

Sponsors & collaborators

Heba Al-Alwanlead sponsor

Swiss National Science Foundationcollaborator

Institute of Primary Health Care (BIHAM), Switzerlandcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06925217 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.